Evidence map›Paper›PMID 42180634›Full record

ArticleFrontiers in health services2026

Examining perceptions, social, and policy factors influencing hepatitis B birth-dose vaccine uptake: a PEN-3 cultural model mixed-methods study of healthcare workers in Nigeria.

Olufunto A Olusanya, Oluwakorede Adedeji, Caven Ngoe, David Oladele, Adesola Z Musa, Maria Afadapa, Titi Gbaja-Biamila, Ifeoma Eugenia Idigbe, Peter Kalulu, Nkiruka Obodoechina and 16 more

Abstract read
In one paragraph

Article in Frontiers in health services, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Olufunto A OlusanyaSt Louis John T Milliken Department of Medicine, Washington University, St. Louis, MO, United States.
Oluwakorede AdedejiDepartment of Clinical Pharmacy and Pharmacy Practice, University of Ilorin, Ilorin, Nigeria.
Caven NgoeSt Louis George Warren Brown School of Social Work, Washington University, St. Louis, MO, United States.
David OladeleNigerian Institute of Medical Research, Lagos, Nigeria.
Adesola Z MusaNigerian Institute of Medical Research, Lagos, Nigeria.
Maria AfadapaSt Louis John T Milliken Department of Medicine, Washington University, St. Louis, MO, United States.
Titi Gbaja-BiamilaNigerian Institute of Medical Research, Lagos, Nigeria.
Ifeoma Eugenia IdigbeNigerian Institute of Medical Research, Lagos, Nigeria.
Peter KaluluSt Louis John T Milliken Department of Medicine, Washington University, St. Louis, MO, United States.
Nkiruka ObodoechinaSt Louis John T Milliken Department of Medicine, Washington University, St. Louis, MO, United States.
Temitope OjoSt Louis John T Milliken Department of Medicine, Washington University, St. Louis, MO, United States.
Folahanmi AkinsoluNigerian Institute of Medical Research, Lagos, Nigeria.
Abideen SalakoNigerian Institute of Medical Research, Lagos, Nigeria.
Joseph OgbehNigerian Institute of Medical Research, Lagos, Nigeria.
Chiamaka OdinammaduSaint Louis University College for Public Health and Social Justice, St. Louis, MO, United States.
Ucheoma NwaozuruDepartment of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Kristi L FoleyDepartment of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Agatha WapmukNigerian Institute of Medical Research, Lagos, Nigeria.
Hong XianSaint Louis University College for Public Health and Social Justice, St. Louis, MO, United States.
Jason J OngDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Peyton ThompsonDivision of Infectious Diseases, The University of North Carolina at Chapel Hill Institute for Global Health and Infectious Diseases, Chapel Hill, NC, United States.
Oluwaseun Falade-NwuliaDivision of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Suzanne DayDivision of Infectious Diseases, The University of North Carolina at Chapel Hill Institute for Global Health and Infectious Diseases, Chapel Hill, NC, United States.
Joseph D TuckerDivision of Infectious Diseases, The University of North Carolina at Chapel Hill Institute for Global Health and Infectious Diseases, Chapel Hill, NC, United States.
Oliver Chukwujekwu EzechiNigerian Institute of Medical Research, Lagos, Nigeria.
Juliet IwelunmorSt Louis John T Milliken Department of Medicine, Washington University, St. Louis, MO, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The timely administration of the birth-dose hepatitis B (HepB-BD) vaccine is recommended by global and national guidelines to effectively prevent perinatal transmission. In high-disease-burden countries, such as Nigeria, the adoption of the HepB-BD vaccine remains limited. Emerging global policy discussions highlight the need to examine healthcare workers' (HCWs') perceptions of pediatric vaccination guidelines, the safety and effectiveness of the HepB-BD vaccine, and how family, social support, and community factors influence vaccine delivery. Methods: A convergent mixed-methods study of HCWs was conducted in Nigeria between July and August 2024. Using the PEN-3 Cultural Model as our framework, we concurrently administered quantitative surveys and conducted in-depth qualitative interviews and focus group discussions to assess knowledge, beliefs, and peer influences related to HepB-BD vaccinations. We also explored HCWs' perceptions, enabling factors, and social influences that impact vaccine delivery. Data were analyzed using descriptive statistics and thematic analysis. Results: Most participants were women (87.8%), nurses (24.4%), and community extension workers (14.6%), with an average age of 32.5 years. Over half perceived HepB-BD vaccines as extremely safe (61%) and effective (63.4%). Participants strongly agreed that birth vaccination is recommended (80.5%), ethically appropriate (68.3%), and that its benefits outweigh side effects (63.4%). Most respondents reported professional autonomy in birth-dose decisions: 51.2% strongly disagreed that family opinions influenced their decisions, and 48.8% strongly disagreed that family/friends were concerned about their administering the vaccine. Qualitative themes included perceptions of barriers (poor knowledge, limited vaccine stock, misinformation), enablers (transportation and cold chain reliability), and nurturing factors (the role of training and collaboration with traditional birth attendants). Misconceptions included linking vaccines to sexually transmitted infections and concerns about fragile newborn immunity. Conclusion: HepB-BD vaccine delivery by HCWs is influenced by a complex interplay of multiple factors, including perceptions, structural enablers, and social relationships. As global policies continue to evolve, programs should adopt culturally responsive, context-specific strategies to address these multi-level influences and foster HCW trust, thereby ensuring the timely delivery of the HepB-BD vaccine.

Indexed as

healthcare workershepatitis BvirusnewbornsPEN-3 cultural modelvaccines

Identifiers

PMID42180634
PMCPMC13190435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.